Joel has experience of contentious and non-contentious matters across a range of intellectual property rights.

Before becoming a solicitor, Joel completed a PhD in the Department of Biochemistry of the University of Cambridge. Joel’s strong life sciences background has been of particular relevance for his recent work relating to pharmaceutical, biotechnology and healthcare technologies, including antibody technologies, genome sequencing, therapeutic microarrays, and wound dressings. In particular, Joel has worked on one of the leading cases relating to the validity and infringement of second medical use patents and Swiss form claims.

Joel has also worked on a number of electronics and mechanical engineering patent cases, and has experience of handling multi-jurisdictional patent actions. In addition to representing clients in litigation before the UK Patents Court and Court of Appeal, Joel has represented clients in European Patent Office opposition proceedings, and advises on patent litigation strategies, freedom to operate, and patent term extensions, including supplementary protection certificates. Joel is a solicitor advocate, and has appeared before the High Court. He is also a member of the California Bar.

Joel joined Powell Gilbert in 2011.

Key cases

  • Warner-Lambert v Actavis & Others (pregabalin)

  • Illumina v Ariosa & Premaitha (non-invasive prenatal testing)

  • Regeneron v Kymab (antibodies/transgenic mice) 

  • Corma v Hegler Plastik (extruded plastics)

  • Rovi v Virgin Media & TiVo (electronics)

  • Motorola Mobility v BT (digital TV)

  • Convatec v Smith & Nephew (wound dressings)

  • Mylan v Sandoz (protein purification)

  • Forty Seven v SSB (therapeutic antibodies)

  • Chugai v UCB (humanised antibodies)

  • Merck v Royalty Pharma (DPP-IV inhibitors)